trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Transplant recipients must take medication for the rest of their lives to prevent the immune system from rejecting the new organ.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that transplant recipients must take medication for the rest of their lives to prevent the immune system from rejecting the new organ?

Yes. Transplant recipients require lifelong immunosuppressive medication to prevent their immune systems from rejecting the transplanted organs.

Verdict: SUPPORTED · 3 sources for, 0 against · Last checked

The analysis

The retrieved literature consistently emphasizes that long-term survival of solid organ transplants depends on ongoing immunosuppressive management to prevent graft rejection.

Evidence for · 3
2026
The systematic review highlights that lifelong management strategies focusing on patient adherence to immunosuppressive therapy are essential for long-term graft longevity in pediatric kidney transplant recipients.
Get citation
NS, A., FM, A., S, A., AM, A., GT, Z., AG, S., HS, A., S, A., M, A., SS, K., BKM, G., & R, D. (2026). Pediatric Kidney Transplantation: A Systematic Review.. doi.org. https://doi.org/10.3390/children13081122

See more details
More for · 2
2026
Postoperative management for laryngeal transplantation emphasizes lifelong surveillance and individualized immunosuppression to prevent rejection.
Get citation
L, Z. & L, W. (2026). Laryngeal transplantation: from experimental feasibility to multidisciplinary clinical reality.. doi.org. https://doi.org/10.3389/fsurg.2026.1833564

2026
The scoping review notes that while immunosuppressive therapies are foundational to solid organ transplantation, long-term therapy is required to manage rejection despite challenges such as patient non-adherence.
Get citation
EA, D., MO, O., WC, E., U, W., H, S., F, S., H, F., & S, T. (2026). Graft rejection across solid organ transplants: mechanisms, monitoring, and immunosuppressive therapeutics.. doi.org. https://doi.org/10.3389/fsurg.2026.1762417

What does the evidence say?

The retrieved literature consistently emphasizes that long-term survival of solid organ transplants depends on ongoing immunosuppressive management to prevent graft rejection.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work